Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in
Jeroen Van Schependom, Kaat Guldolf, Marie D’hooghe, et al.
Translational Neurodegeneration (2019) Vol. 8, Iss. 1
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Advances in Neurodegenerative Diseases
Jeroen Van Schependom, Miguel D’haeseleer
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1709-1709
Open Access | Times Cited: 80
Amyloid-beta and tau protein beyond Alzheimer’s disease
Morteza Abyadeh, Vivek Gupta, João A. Paulo, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 6, pp. 1262-1276
Open Access | Times Cited: 39
The Role of Vitamin D in Neuroprotection in Multiple Sclerosis: An Update
Amarpreet Sangha, Michaela Quon, Gerald Pfeffer, et al.
Nutrients (2023) Vol. 15, Iss. 13, pp. 2978-2978
Open Access | Times Cited: 28
A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial
Anna-Victoria De Keersmaecker, Eline Van Doninck, Veronica Popescu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Topographical Mapping of Metabolic Abnormalities in Multiple Sclerosis using Rapid Echo-less 3D-MR Spectroscopic Imaging at 7T
Eva Niess, Assunta Dal‐Bianco, Bernhard Strasser, et al.
NeuroImage (2025), pp. 121043-121043
Open Access | Times Cited: 1
Approved and Emerging Disease Modifying Therapies on Neurodegeneration in Multiple Sclerosis
Madeline Bross, Melody Hackett, Evanthia Bernitsas
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4312-4312
Open Access | Times Cited: 54
The Two Sides of Siponimod: Evidence for Brain and Immune Mechanisms in Multiple Sclerosis
Stanley Cohan, Ralph H. B. Benedict, Bruce Cree, et al.
CNS Drugs (2022) Vol. 36, Iss. 7, pp. 703-719
Open Access | Times Cited: 24
Advanced MRI Techniques: Diagnosis and Follow-Up of Multiple Sclerosis
Riccardo Nistri, Antonio Ianniello, Valeria Pozzilli, et al.
Diagnostics (2024) Vol. 14, Iss. 11, pp. 1120-1120
Open Access | Times Cited: 5
Comorbidity in multiple sclerosis: Past, present and future
Ruth Ann Marrie
Clinical and investigative medicine (2019) Vol. 42, Iss. 1, pp. E5-E12
Open Access | Times Cited: 39
Cognitive Impairment and Brain Reorganization in MS: Underlying Mechanisms and the Role of Neurorehabilitation
Grigorios Nasios, Christos Bakirtzis, Lambros Messinis
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 36
Proteomics of Multiple Sclerosis: Inherent Issues in Defining the Pathoetiology and Identifying (Early) Biomarkers
Monokesh Kumer Sen, Mohammed S. M. Almuslehi, Peter Shortland, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7377-7377
Open Access | Times Cited: 27
Early-stage volume losses in the corpus callosum and thalamus predict the progression of brain atrophy in patients with multiple sclerosis
Juichi Fujimori, Ichiro Nakashima
Journal of Neuroimmunology (2024) Vol. 387, pp. 578280-578280
Open Access | Times Cited: 4
Biomechanical perspectives on traumatic brain injury in the elderly: A comprehensive review
Hamed Abdi, David Sánchez‐Molina, Silvia García‐Vilana, et al.
Progress in Biomedical Engineering (2025) Vol. 7, Iss. 2, pp. 022001-022001
Closed Access
Exosome-based platforms for treatment of multiple sclerosis
Aidin Mohammadi Zonouz, Mahboobeh Ghasemzadeh Rahbardar, Mona Alibolandi
Brain Research Bulletin (2025) Vol. 222, pp. 111256-111256
Open Access
Fluid-based biomarkers for neurodegenerative diseases
Yongliang Cao, Yifei Xu, Meiqun Cao, et al.
Ageing Research Reviews (2025), pp. 102739-102739
Open Access
Frontoparietal connectivity correlates with working memory performance in multiple sclerosis
Alejandra Figueroa-Vargas, Claudia Cárcamo, Rodrigo Henriquez, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 31
Cognitive Decline in Multiple Sclerosis Is Related to the Progression of Retinal Atrophy and Presence of Oligoclonal Bands: A 5-Year Follow-Up Study
Nataša Giedraitienė, Eglė Drukteinienė, Rasa Kizlaitienė, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 21
Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer’s disease and multiple sclerosis: a systematic review
Joke Temmerman, Sebastiaan Engelborghs, Maria Bjerke, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
An investigation of the effect of brain atrophy on brain injury in multiple sclerosis
Hamed Abdi, Kamran Hassani, Shahrokh Shojaei
Journal of Theoretical Biology (2022) Vol. 557, pp. 111339-111339
Closed Access | Times Cited: 12
Brain microstructural injury occurs in patients with RRMS despite ‘no evidence of disease activity’
Asaff Harel, Dylan Sperling, Maria Petracca, et al.
Journal of Neurology Neurosurgery & Psychiatry (2018) Vol. 89, Iss. 9, pp. 977-982
Closed Access | Times Cited: 17
Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation
Graham Cooper, Claudia Chien, Hanna Zimmermann, et al.
Multiple Sclerosis Journal (2021) Vol. 27, Iss. 14, pp. 2180-2190
Open Access | Times Cited: 14
Emerging evidence for compromised axonal bioenergetics and axoglial metabolic coupling as drivers of neurodegeneration
Bogdan Beirowski
Neurobiology of Disease (2022) Vol. 170, pp. 105751-105751
Closed Access | Times Cited: 8
The Nano and Artificial Intelligence Effect: Improved Magnetic Resonance Imaging Volumetry for Multiple Sclerosis
Alrayan F. Nahhas, Alaa F. Nahhas, Thomas J. Webster
OpenNano (2024) Vol. 18, pp. 100209-100209
Open Access | Times Cited: 1
Serum Vitamin D3 as a Potential Biomarker for Neuronal Damage in Smoldering Multiple Sclerosis
Natalia Niedziela, Maria Nowak, Lina Malcienė, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10502-10502
Open Access | Times Cited: 1
Cognitive impairment and markers of optical neurodegeneration in early multiple sclerosis
Renata Silva, Pedro Coelho, Mafalda Seabra, et al.
Neurological Sciences (2022) Vol. 43, Iss. 7, pp. 4381-4386
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top